Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma.
about
MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expressionMethylated circulating tumor DNA in blood: power in cancer prognosis and responsePredictive value of epigenetic alterations in head and neck squamous cell carcinomaEpigenetic impact of infection on carcinogenesis: mechanisms and applicationsEpigenetic disruption of cell signaling in nasopharyngeal carcinoma.Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinomaHypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer.Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population.A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinomaThe plasma DNA concentration as a potential breast cancer screening marker.Biomarkers for risk assessment in molecular epidemiology of cancer.Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma.10. Circulating Nucleic Acids as Diagnostic ToolComparison of circulating plasma DNA levels between lung cancer patients and healthy controls.DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiologyGenetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis.Selection of reliable reference genes for gene expression study in nasopharyngeal carcinoma.DNA methylation testing and marker validation using PCR: diagnostic applications.Mixed exocrine-neuroendocrine carcinoma of the nasal cavity: clinico-pathologic and molecular study of a case and review of the literature.DNA methylation and cancer development: molecular mechanism.Biomarker discovery of nasopharyngeal carcinoma by proteomics.Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma.Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation.A Rare Presentation of Primary Nasopharyngeal Carcinoma (NPC) in Mediastinum.p16 promoter hypermethylation is associated with increased risk of nasopharyngeal carcinoma.Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer.Serum, plasma and saliva biomarkers for head and neck cancer.Diagnostic potential of methylated in brushing samples of nasopharyngeal carcinoma
P2860
Q24628370-49C6996F-4EFF-4C1A-8EA0-9844ACC291AEQ26772077-5AC647A3-9AA6-41EE-9AFA-CAF24C24EC46Q27690755-1B540642-654D-4948-B53B-ECC0F7E77FC5Q28066519-51617ECC-BD8B-405A-BC6A-7DB34A65BE54Q33579472-33D126F5-B96B-4FCA-96BF-20CE276495A3Q33603685-45F4D117-691A-4C0D-839B-C05D2846F170Q33718940-A94BF4E9-BD24-4DAB-B60A-79C9EB4B38CAQ33808960-C884CD8B-77BA-4167-AAAC-B02E46FA17C8Q33887581-EEDA5464-382A-4E8F-A039-354666C6CCA5Q34200303-EDC56248-693D-416E-9092-765C08DD6403Q35028065-73193BBA-DD7E-45FC-A96F-D207022AAFC1Q35904013-BEA39D92-BD0F-4B6F-A5B0-B2EA5D2C4CECQ36443927-71B1DD1A-729F-4020-91B0-86D167160149Q37155440-E860D5A3-555C-4DCE-A808-0B1C60C52D00Q37164447-8094F7A3-DAF9-44FD-8C68-3F69D3581200Q37234443-DCF93867-D647-49EF-ACF6-6D94E59A0602Q37453787-CAB6E08A-AB5A-40B5-919C-B701F7238C04Q37729875-66E4B048-CE5F-4C14-B679-A6615946FBD8Q37963517-14B93026-5EC2-4E74-A053-ED40081B3E9BQ38022203-06E7FD38-E180-4D30-9029-19639C1A4E60Q38091024-A403343B-82B1-4E85-9395-830495BBC595Q38194579-FF88B90E-711B-4F56-B29F-2C138482C4E4Q38959017-28BFFCB6-5873-4441-BE7D-79C2EB5CD9AFQ39151547-447A534A-DF85-4715-BF2A-951C4B89FC97Q40487971-3899B533-2574-437B-B176-0A834B0308A2Q40530241-F3DE9AE4-47F2-456E-87C6-7C0DF3B984F1Q42921451-3B5A8D4B-25F2-4B03-AB16-460A893296DFQ46860787-06EB848D-F74B-4C7E-8A27-16F2C2F23FE5Q47405806-D781B47B-B2DC-4BA8-B336-8821A15BE12FQ58698636-D6FBA15A-3745-4A05-AB89-48BEB9918BF4
P2860
Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Quantitative plasma hypermethy ...... ated nasopharyngeal carcinoma.
@en
Quantitative plasma hypermethy ...... ated nasopharyngeal carcinoma.
@nl
type
label
Quantitative plasma hypermethy ...... ated nasopharyngeal carcinoma.
@en
Quantitative plasma hypermethy ...... ated nasopharyngeal carcinoma.
@nl
prefLabel
Quantitative plasma hypermethy ...... ated nasopharyngeal carcinoma.
@en
Quantitative plasma hypermethy ...... ated nasopharyngeal carcinoma.
@nl
P2093
P1476
Quantitative plasma hypermethy ...... iated nasopharyngeal carcinoma
@en
P2093
Anthony Po-Wing Yuen
Dora Lai-Wan Kwong
Jonathan Shun-Tong Sham
Thian-Sze Wong
Yok-Lam Kwong
P304
P356
10.1158/1078-0432.CCR-03-0139
P407
P577
2004-04-01T00:00:00Z